An Explorative Review on Advanced Approaches to Overcome Bacterial Resistance by Curbing Bacterial Biofilm Formation
F Mohamad,Raghad R Alzahrani,Ahlam Alsaadi,Bahauddeen M Alrfaei,Alaa Eldeen B Yassin,Manal M Alkhulaifi,Majed Halwani
DOI: https://doi.org/10.2147/IDR.S380883
2023-01-05
Infection and Drug Resistance
Abstract:F Mohamad, 1, * Raghad R Alzahrani, 2, 3, * Ahlam Alsaadi, 1 Bahauddeen M Alrfaei, 4 Alaa Eldeen B Yassin, 5 Manal M Alkhulaifi, 3 Majed Halwani 2 1 Infectious Diseases Research Department, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 2 Nanomedicine Department, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 3 Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia; 4 Stem Cells and Regenerative Medicine, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 5 College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia *These authors contributed equally to this work Correspondence: Majed Halwani, P.O. Box 3660, Mail Code 1515 (KAIMRC), Riyadh, 11481, Tel +966 (11) 429-4433, Fax +966 (11) 429-4440, Email ; Manal M Alkhulaifi, P.O. Box 55670, Riyadh, 11544, Tel +966 (11) 805-1685, Email The continuous emergence of multidrug-resistant pathogens evoked the development of innovative approaches targeting virulence factors unique to their pathogenic cascade. These approaches aimed to explore anti-virulence or anti-infective therapies. There are evident concerns regarding the bacterial ability to create a superstructure, the biofilm. Biofilm formation is a crucial virulence factor causing difficult-to-treat, localized, and systemic infections. The microenvironments of bacterial biofilm reduce the efficacy of antibiotics and evade the host's immunity. Producing a biofilm is not limited to a specific group of bacteria; however, Pseudomonas aeruginosa, Acinetobacter baumannii , and Staphylococcus aureus biofilms are exemplary models. This review discusses biofilm formation as a virulence factor and the link to antimicrobial resistance. In addition, it explores insights into innovative multi-targeted approaches and their physiological mechanisms to combat biofilms, including natural compounds, phages, antimicrobial photodynamic therapy (aPDT), CRISPR-Cas gene editing, and nano-mediated techniques. Keywords: bacterial biofilms, natural compounds, phages, aPDT, CRISPR, nanotechnology Considering the physiological role of bacterial virulence factors when targeting bacteria using conventional antibiotics is promising. Bacterial pathogenesis depends on protein-protein intercommunication, which is surface-bound or secreted to interact with the host-specific molecules or defense system. 1 The virulence of microbes is key to enabling them to invade a host, surpass its immune system, and cause an infection. The microbial elements accomplishing this invasion are called "virulence factors". 2 The function of virulence factors is not to instigate the infection; however, it aids the bacteria in surviving hostile environments (ie, the host's body), resulting in cellular damage. 3 This virulence intensifies the ability of the bacterial cell to establish an organized community called biofilm, 10–1000 times more potent than the sessile bacterial cell when treated with conventional antibiotics. 4 Bacterial cells in the biofilm are contained in a self-produced polymeric extracellular matrix (ECM), 2 and its characteristics are summarized in Figure 1. 7, 8 , 10 , 11 The altered phenotypic features in biofilm-forming bacteria include decreasing the transcriptional gene expression and translating proteins essential for bacterial cell metabolism, resulting in reduced metabolic activity. 4,5 Biofilm formation increases the genes' expressing qualities, including adherence, quorum-sensing systems, and competence. 6 The secretion of the ECM layer follows successful adherence, which causes colony formation and maturation. The biofilm is dispersed to spread and localize to other sites. 7–9 These interactions are controlled through a system known as quorum-sensing (QS), QS signaling molecules accumulate according to cell density. 10 These molecules promote biofilm maturation and dispersion and regulate the expression of specific biofilm-related genes and proteins, such as algC, fap, ica operon, gtfBCD , and CsgD. 7,11 Consequently, understanding the genetic and phenotypic interactions is essential to comprehend the development of biofilms during infection and to understand the crosstalk linking bacteria within the biofilm and their infl -Abstract Truncated-
pharmacology & pharmacy,infectious diseases